CVE-2026-4622

CRITICALCVSS 9.8/10EPSS 0.86%

Last modified

CVE-2026-4622 is a critical-severity vulnerability rated 9.8/10 on the CVSS scale. OS Command Injection vulnerability in NEC Platforms, Ltd. Aterm Series allows a attacker to execute arbitrary OS commands via network.. EPSS estimates a 0.86% chance of exploitation in the next 30 days.

Description

OS Command Injection vulnerability in NEC Platforms, Ltd. Aterm Series allows a attacker to execute arbitrary OS commands via network.

Metrics

Weakness Enumeration

Affected Software

VendorProductVersions
NecAterm Wg2600hs Firmware< 1.7.2
NecAterm Wf1200cr Firmware< 1.6.0
NecAterm Wg1200cr Firmware< 1.5.0
NecAterm Wg2600hp4 Firmware< 1.4.2
NecAterm Wg2600hm4 Firmware< 1.4.2
NecAterm Wg2600hs2 Firmware< 1.3.2
NecAterm Wx3000hp Firmware< 2.5.0
NecAterm Wx3000hp2 Firmware< 1.3.2
NecAterm Gb1200pe Firmware< 1.3.1

References

Timeline

Published
Last Modified
Status
Analyzed

Frequently Asked Questions

What is CVE-2026-4622?
OS Command Injection vulnerability in NEC Platforms, Ltd. Aterm Series allows a attacker to execute arbitrary OS commands via network.
How severe is CVE-2026-4622?
CVE-2026-4622 has a CVSS score of 9.8/10 (CRITICAL severity). The EPSS model estimates a 0.86% probability of exploitation in the next 30 days.
How do I fix CVE-2026-4622?
Check the vendor references and advisories linked above for patched versions and mitigation guidance. You can also run a Strix scan to test if your systems are affected.

How Strix Helps

Related CVEs from 2026

Are you affected by CVE-2026-4622?

Run a free Strix scan to check your systems for this vulnerability.

Scan your code now

Source: NVD / NIST